Related Experiment Video

Updated: Jul 6, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability

F Al-Mulla1, S Hagan, W Al-Ali

  • 1Department of Pathology, Molecular Pathology Unit, Faculty of Medicine, Kuwait University, Kuwait. fahd@al-mulla.org

Journal of Clinical Pathology
|April 1, 2008
PubMed
Abstract

Insights

Loss of Raf kinase inhibitory protein (RKIP) in colorectal cancer is linked to increased chromosomal instability. Promoter methylation is a key mechanism causing RKIP silencing, potentially driving cancer metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Raf kinase inhibitory protein (RKIP) inhibits the Raf-MAPK pathway and acts as a metastasis suppressor in various cancers, including colorectal cancer (CRC).
  • RKIP regulates the spindle checkpoint in cultured cells, suggesting a role in chromosomal stability.

Purpose of the Study:

  • To correlate RKIP expression with chromosomal instability in colorectal cancer (CRC) samples.
  • To identify mechanisms responsible for RKIP loss in CRC.

Main Methods:

  • Comparative genomic hybridization (CGH) and loss of heterozygosity (LOH) assessed chromosomal instability in 65 microsatellite-stable (MSS) CRC cases.
  • Methyl-specific PCR analyzed RKIP promoter CpG methylation in 82 CRC cases, correlating results with RKIP protein expression.

Main Results:

  • A significant inverse correlation was found between chromosomal losses and RKIP expression in MSS CRC.
  • RKIP promoter hypermethylation was identified as a primary mechanism for RKIP gene silencing in CRC.

Conclusions:

  • RKIP promoter hypermethylation contributes to aneuploidy in colorectal cancer.
  • Loss of RKIP may significantly influence metastatic progression in CRC.

More Related Videos

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...